 |
|
|
|
|
|
|
|
|
|
|
|
1 to 6 of 6 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Leissring M. on NEWS: Novel Aβ Protease Found in Mitochondria, Our group recently discovered that insulin-degrading enzyme (IDE) itself is targeted to... 1 Aug 2006.
|
|
|
 |
|
|
Leissring M. on NEWS: MCI—Hippocampal IDE, Parahippocampal White Matter in Decline, I really like this paper and think it is quite important. However, some caution should be given... 22 Jun 2006.
|
|
|
|
|
|
Leissring M. on NEWS: Metalloproteases—A Shining Challenge to Aβ, Back in the good old days, when AD research was hyperfocused on Aβ production and aggregation,... 13 May 2006.
|
|
|
|
|
|
Leissring M. on NEWS: The Theology of Aβ: Presenilins Giveth, and They Taketh Away, The manuscript by Pardossi-Piquard et al. (Neuron, 2005) provides an impressive array of... 23 May 2005.
|
|
|
|
|
|
Leissring M. on NEWS: Aβ, Shifty Drifter? Tissue Grafting Sheds Light on Plaque Formation, The paper by Meyer-Luehmann et al. takes a novel approach to investigating the mechanisms of... 3 Mar 2003.
|
|
|
|
|
|
Leissring M. on LIVE DISCUSSION: β Amyloid Degradation: The Forgotten Half of Alzheimer's Disease, Reply by Malcolm Leissring
Dr. Kurochkin's correctly notes that IDE does not... 11 Sep 2002.
|
|
|
|
|
|
|
1 to 6 of 6 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
See our latest Webinar: 
